PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
23970434-0	2013	Effects of polymorphisms of the SLCO2B1 transporter gene on the pharmacokinetics of montelukast in humans.	montelukast	84-95	solute carrier organic anion transporter family member 2B1	Homo sapiens	32-39	
26694455-1	2015	Clinical studies with montelukast show variability in effect and polymorphic OATP2B1-dependent absorption has previously been implicated as a possible cause.	montelukast	22-33	solute carrier organic anion transporter family member 2B1	Homo sapiens	77-84	
26694455-4	2015	Montelukast is a carboxylic acid, a relatively potent inhibitor of OATP1B1, OATP1B3, and OATP2B1, and has previously been postulated to be actively transported into human hepatocytes.	montelukast	0-11	solute carrier organic anion transporter family member 2B1	Homo sapiens	89-96	
23970434-1	2013	Montelukast, a leukotriene receptor antagonist, is a substrate of organic anion transporting OATP2B1 encoded by the SLCO2B1.	montelukast	0-11	solute carrier organic anion transporter family member 2B1	Homo sapiens	93-100	
23970434-1	2013	Montelukast, a leukotriene receptor antagonist, is a substrate of organic anion transporting OATP2B1 encoded by the SLCO2B1.	montelukast	0-11	solute carrier organic anion transporter family member 2B1	Homo sapiens	116-123	
20974993-0	2011	Effect of citrus juice and SLCO2B1 genotype on the pharmacokinetics of montelukast.	montelukast	71-82	solute carrier organic anion transporter family member 2B1	Homo sapiens	27-34	
23151832-1	2013	OBJECTIVE: A nonsynonymous single nucleotide polymorphism (SNP) in the SLCO2B1 gene encoding organic anion transporting polypeptide 2B1 (OATP2B1), c.935G>A (p.R312Q; rs12422149), has been associated with reduced plasma concentrations of montelukast in patients with asthma.	montelukast	240-251	solute carrier organic anion transporter family member 2B1	Homo sapiens	71-78	
23151832-1	2013	OBJECTIVE: A nonsynonymous single nucleotide polymorphism (SNP) in the SLCO2B1 gene encoding organic anion transporting polypeptide 2B1 (OATP2B1), c.935G>A (p.R312Q; rs12422149), has been associated with reduced plasma concentrations of montelukast in patients with asthma.	montelukast	240-251	solute carrier organic anion transporter family member 2B1	Homo sapiens	93-135	
23151832-1	2013	OBJECTIVE: A nonsynonymous single nucleotide polymorphism (SNP) in the SLCO2B1 gene encoding organic anion transporting polypeptide 2B1 (OATP2B1), c.935G>A (p.R312Q; rs12422149), has been associated with reduced plasma concentrations of montelukast in patients with asthma.	montelukast	240-251	solute carrier organic anion transporter family member 2B1	Homo sapiens	137-144	
23151832-2	2013	Our aim was to examine the possible effects of the SLCO2B1 c.935G>A SNP on the single-dose pharmacokinetics of the suggested OATP2B1 substrates montelukast and aliskiren.	montelukast	147-158	solute carrier organic anion transporter family member 2B1	Homo sapiens	51-58	
23151832-2	2013	Our aim was to examine the possible effects of the SLCO2B1 c.935G>A SNP on the single-dose pharmacokinetics of the suggested OATP2B1 substrates montelukast and aliskiren.	montelukast	147-158	solute carrier organic anion transporter family member 2B1	Homo sapiens	128-135	
20974993-1	2011	Previously the authors found that a common polymorphism, rs12422149 (SLCO2B1{NM_007256.2}:c.935G>A), in the gene coding for OATP2B1, was associated with absorption of and response to montelukast in humans.	montelukast	186-197	solute carrier organic anion transporter family member 2B1	Homo sapiens	69-76	
20974993-1	2011	Previously the authors found that a common polymorphism, rs12422149 (SLCO2B1{NM_007256.2}:c.935G>A), in the gene coding for OATP2B1, was associated with absorption of and response to montelukast in humans.	montelukast	186-197	solute carrier organic anion transporter family member 2B1	Homo sapiens	127-134	
19151602-7	2009	An MDCKII cell line expressing OATP2B1 (coded for by the SLCO2B1 gene) displays significantly increased permeability of montelukast (P<0.05, percentage of control: 140+/-20).	montelukast	120-131	solute carrier organic anion transporter family member 2B1	Homo sapiens	31-38	
19151602-9	2009	CONCLUSION: Altogether, these observations suggest that the genetics of SLCO2B1 may be an important variable in determining the pharmacokinetics and the pharmacodynamics of montelukast.	montelukast	173-184	solute carrier organic anion transporter family member 2B1	Homo sapiens	72-79